IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CASULA, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 28.618
AS - Asia 21.718
NA - Nord America 14.841
SA - Sud America 4.736
AF - Africa 1.402
OC - Oceania 938
Continente sconosciuto - Info sul continente non disponibili 63
Totale 72.316
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.992
CN - Cina 7.947
IT - Italia 5.276
DE - Germania 4.131
ES - Italia 3.284
GB - Regno Unito 3.158
BR - Brasile 2.126
SG - Singapore 2.075
IN - India 1.863
FR - Francia 1.844
MX - Messico 1.642
JP - Giappone 1.635
HK - Hong Kong 1.113
VN - Vietnam 1.066
RU - Federazione Russa 990
CH - Svizzera 954
TR - Turchia 910
NL - Olanda 899
CO - Colombia 892
SE - Svezia 892
KR - Corea 844
ID - Indonesia 841
CA - Canada 819
AU - Australia 794
PL - Polonia 792
AT - Austria 790
PT - Portogallo 759
GR - Grecia 663
TW - Taiwan 631
TH - Thailandia 543
AR - Argentina 541
IE - Irlanda 532
FI - Finlandia 517
BE - Belgio 495
DK - Danimarca 482
EG - Egitto 456
PE - Perù 395
BD - Bangladesh 328
CL - Cile 326
RO - Romania 301
EC - Ecuador 280
SA - Arabia Saudita 243
ZA - Sudafrica 238
MY - Malesia 237
NO - Norvegia 233
IL - Israele 225
HR - Croazia 208
CZ - Repubblica Ceca 198
IR - Iran 174
PH - Filippine 167
SI - Slovenia 152
AE - Emirati Arabi Uniti 144
RS - Serbia 143
UA - Ucraina 143
NZ - Nuova Zelanda 137
SK - Slovacchia (Repubblica Slovacca) 134
HU - Ungheria 130
PK - Pakistan 122
TN - Tunisia 117
BG - Bulgaria 116
CR - Costa Rica 102
LT - Lituania 95
MA - Marocco 93
DZ - Algeria 87
LB - Libano 80
BA - Bosnia-Erzegovina 77
VE - Venezuela 74
CI - Costa d'Avorio 70
IQ - Iraq 69
NG - Nigeria 68
CY - Cipro 60
JO - Giordania 60
EE - Estonia 56
DO - Repubblica Dominicana 52
QA - Qatar 48
UY - Uruguay 46
KE - Kenya 43
ET - Etiopia 42
GT - Guatemala 37
PA - Panama 36
KW - Kuwait 34
LV - Lettonia 33
KZ - Kazakistan 32
BO - Bolivia 31
EU - Europa 31
BY - Bielorussia 29
NP - Nepal 28
MO - Macao, regione amministrativa speciale della Cina 27
HN - Honduras 26
AP - ???statistics.table.value.countryCode.AP??? 25
PY - Paraguay 24
SV - El Salvador 23
LK - Sri Lanka 22
GH - Ghana 20
CU - Cuba 19
OM - Oman 19
PR - Porto Rico 19
SN - Senegal 19
AL - Albania 18
IS - Islanda 18
Totale 71.871
Salva come PNG Salva come JPEG
Città #
Singapore 1.204
Beijing 996
Milan 948
Southend 817
Ashburn 759
Shanghai 672
Madrid 600
Tokyo 581
Hong Kong 555
Frankfurt am Main 509
San Jose 477
Vienna 471
New York 455
Rome 453
Guangzhou 450
Los Angeles 439
Barcelona 429
Bogotá 374
Dublin 373
Ho Chi Minh City 373
Paris 355
Hanoi 339
Istanbul 334
London 330
Athens 320
Taipei 316
São Paulo 314
Redwood City 310
Berlin 300
Bangkok 291
Helsinki 289
Mumbai 276
Bormujos 273
Munich 271
Lima 262
Dallas 257
Moscow 256
Warsaw 255
Chicago 253
Nanjing 248
Council Bluffs 246
Zurich 246
Sydney 244
Bengaluru 243
Cairo 236
Jakarta 231
Fairfield 222
Hefei 211
Buenos Aires 210
Hanover 208
Stockholm 207
Seattle 206
Amsterdam 204
Chandler 202
Mexico City 202
Melbourne 201
Wuhan 182
Houston 177
Seoul 177
Chennai 175
Chengdu 174
Naples 173
Lisbon 171
Santiago 170
Hangzhou 166
Brussels 163
Duncan 163
Medellín 156
Tianjin 156
Wilmington 152
Bologna 149
Atlanta 147
Central 146
Copenhagen 146
Ankara 141
Florence 139
Hyderabad 139
Hamburg 134
Toronto 134
Zagreb 129
Valencia 126
Santa Clara 125
Kuala Lumpur 123
Changsha 120
Cambridge 119
Rio de Janeiro 118
Menlo Park 117
Princeton 115
Woodbridge 115
Turin 114
Delhi 113
Shenzhen 113
Manchester 112
Guadalajara 109
Porto 108
Shenyang 107
Ann Arbor 105
Montreal 104
Quito 102
Oslo 100
Totale 27.327
Salva come PNG Salva come JPEG
Nome #
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk 36.778
2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk 10.860
Statin use and risk of dementia or Alzheimer's disease : a systematic review and meta-analysis of observational studies 5.996
Statin use and risk of new-onset diabetes : A meta-analysis of observational studies 3.662
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 947
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 926
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 530
Use of proton pump inhibitors and risk of ischemic events in the general population 483
Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: need for customisation strategies 445
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 421
Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database 320
Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study 315
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting : the PROSISA Study 294
Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study 247
Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review 240
Prevalence of the prescription of potentially interacting drugs 231
Multilevel Models to Estimate Carotid Intima-Media Thickness Curves for Individual Cardiovascular Risk Evaluation 225
Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues : a Retrospective Population-Based Cohort Study 222
Global epidemiology of dyslipidaemias 222
Reduction of cardio-metabolic risk and body weight through a multiphasic very-low calorie ketogenic diet program in women with overweight/obesity: A study in a real-world setting 217
Reply to: "Statins probably do not cause cataracts" 206
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub-study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 203
Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study 199
Detection of familial hypercholesterolemia in patients from a general practice database 196
Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies 195
HDL in atherosclerotic cardiovascular disease : In search of a role 193
Epidemiology of cardiovascular risk factors in two population-based studies 177
Global perspective of familial hypercholesterolaemia : a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 174
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials 173
Risk Factors Distribution and Cardiovascular Disease Prevalence in a Representative Sample of Italian Population: The CHECK Study 172
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 165
Cardiovascular events with PCSK9 inhibitors : an updated meta-analysis of randomised controlled trials 165
Longevity-associated BPIFB4 gene counteracts the inflammatory signaling. 164
Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment 163
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 163
Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials 162
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events 161
Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy : the CHECK Study 160
How registers could enhance knowledge and characterization of genetic dyslipidaemias : The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia 158
Effect on C‐reactive protein levels of the addition of ezetimibe, bempedoic acid, or colchicine to statin treatment: A network meta‐analysis 152
Are generic and brand-name statins clinically equivalent? Evidence from a real data-base 152
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 149
Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis 146
Lipid Lowering and Incidence of Cataract, a Role for Fibrates 144
Statins and the risk of diabetes : evidence from a large population-based cohort study 143
Tools to investigate and avoid drug-hypersensitivity in drug development 142
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 142
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG Project 140
Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012–2018 in Piedmont, Italy 140
Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population 139
Corrigendum to “Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database” [Diabetes Res. Clin. Pract. (2015) 108(2) (243–249)] (S0168822715001138)(10.1016/j.diabres.2015.02.013) 139
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 138
Adherence to lipid-lowering treatment : the patient perspective 137
Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial 136
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 136
Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction 135
A simple informative intervention in primary care increases statin adherence 133
Drug treatment and adherence of subjects <40 years with diagnosis of heterozygous familial hypercholesterolemia 133
Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) andtriglyceride-rich lipoprotein metabolism: Facts and gaps 133
Nutraceuticals for dyslipidaemia and glucometabolic diseases : what the guidelines tell us (and do not tell, yet) 132
Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials 131
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia : Implications for clinical diagnosis 127
Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative Databases 125
How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort 125
Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease : The POSTER study 124
C-reactive protein distribution and correlation with traditional cardiovascular risk factors in the Italian population 123
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease 123
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries 122
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolemia: insights from the Italian LIPIGEN Registry 121
Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA) 119
Statin use and risk of cataract : a nested case-control study within a healthcare database 119
Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy 118
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review 114
A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study 113
Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies 109
Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study 106
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 106
Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry 105
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 105
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National Lipigen Registry 104
Antibiotic Prescription in the Community-Dwelling Elderly Population in Lombardy, Italy: A Sub-Analysis of the EDU.RE.DRUG Study 104
Reaching LDL-c targets in high-risk patients requires high-efficacy cholesterol-lowering drugs in more than 50% of cases. The results of the CHECK study 103
Appropriateness of the Prescription and Use of Medicines: An Old Concept but More Relevant than Ever 102
Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review 102
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk 96
High-potency statins increase the risk of acute kidney injury : evidence from a large population-based study 94
A newly developed method for assessing co-exposure to free dose combinations: a proof-of-concept study using antihypertensive medications in Danish registers 87
null 86
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 84
Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy's first wave of the COVID-19 pandemic 83
Enhancing Medication Adherence in Older Adults: A Systematic Review of Evidence‐Based Strategies 78
Attitudes and confidence toward deprescribing: a survey among Italian general practitioners 75
Prescrizione dei farmaci per la terapia dell’osteoporosi nella ASL di Bergamo: anni 2006, 2007 e 2008 = Prescription of anti-osteoporosis drugs during 2006-2008 in an Italian local health unit 73
Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials 67
Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk 45
PCSK9 inhibition in statin-intolerant HeFH patients : what's new? 6
ARE WE UNDERESTIMATING THE BENEFITS OF LIPID-LOWERING THERAPIES? 1
Totale 73.496
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.404
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021499 0 0 0 0 0 0 0 0 0 0 0 499
2021/20228.938 659 686 755 760 745 620 704 1.057 961 662 668 661
2022/202310.091 594 533 605 644 690 813 970 1.128 1.094 850 1.115 1.055
2023/202415.063 1.184 1.151 1.304 1.453 1.557 1.015 1.168 1.209 1.228 1.202 1.393 1.199
2024/202515.276 1.134 1.340 1.104 1.283 1.338 1.036 1.080 1.293 1.393 1.319 1.430 1.526
2025/202616.728 1.644 1.423 1.549 1.443 1.624 1.240 1.860 1.191 1.785 1.249 1.436 284
Totale 73.496